Terms: = Gastric cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Treatment
12395 results:
1. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Gene Single Nucleotide Polymorphism Detection in gastric cancer Based on Ion Semiconductor Sequencing Platform.
Huang K; Yan X; Huang Z; Liang H; Li Z; Wang M; Wan Y; Wang S; Zhao L
J Vis Exp; 2024 May; (207):. PubMed ID: 38801272
[TBL] [Abstract] [Full Text] [Related]
3. Effect of anti-claudin 18.2 monoclonal antibody zolbetuximab alone or combined with chemotherapy or programmed cell death-1 blockade in syngeneic and xenograft gastric cancer models.
Nishibata T; Weng J; Omori K; Sato Y; Nakazawa T; Suzuki T; Yamada T; Nakajo I; Kinugasa F; Türeci Ö; Şahin U; Yoshida T
J Pharmacol Sci; 2024 Jul; 155(3):84-93. PubMed ID: 38797537
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract] [Full Text] [Related]
5. Preoperative abnormal bone mineral density as a prognostic indicator in patients undergoing gastrectomy for gastric cancer: A cohort study.
An S; Eo W
Medicine (Baltimore); 2024 May; 103(21):e38251. PubMed ID: 38788023
[TBL] [Abstract] [Full Text] [Related]
6. Premature mortality for patients after completely resected early adenocarcinoma of the esophagus or stomach.
Bollschweiler E; Hölscher AH; Markar SR; Alakus H; Drebber U; Mönig SP; Plum PS
Cancer Med; 2024 May; 13(10):e7223. PubMed ID: 38778711
[TBL] [Abstract] [Full Text] [Related]
7. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
8. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
9. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of different treatment strategies for T3N1-3 stage gastric cancer based on the SEER database.
Tan Y; Liu S; Tao S; Cheng H; Huang M; Tang Q
Sci Rep; 2024 May; 14(1):11210. PubMed ID: 38755237
[TBL] [Abstract] [Full Text] [Related]
11. The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis.
Li JB; Lai MY; Lin ZC; Guan WL; Sun YT; Yang J; Wang WX; Yang ZR; Qiu MZ
Cancer Immunol Immunother; 2024 May; 73(7):132. PubMed ID: 38753055
[TBL] [Abstract] [Full Text] [Related]
12. [Clinical characteristics and prognosis analysis of gastric cancer patients with bone metastasis].
Zhang MM; Lai M; Li YT; An Y; Yuan WZ
Zhonghua Zhong Liu Za Zhi; 2024 May; 46(5):438-448. PubMed ID: 38742357
[No Abstract] [Full Text] [Related]
13. Nutritional responsiveness affects novel neutrophil parameters and reduces in-hospital mortality and costs in elective cancer oesophagectomy - a single centre, prospective, observational study.
Kutnik P; Borys M; Nurczyk K; Domerecka W; Dziedzic J; Buszewicz G; Teresiński G; Donica H; Piwowarczyk P; Czuczwar M
Anaesthesiol Intensive Ther; 2024; 56(1):77-82. PubMed ID: 38741447
[TBL] [Abstract] [Full Text] [Related]
14. Feasibility of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor with tumor diameter of >5 cm.
Iwakawa Y; Nishi M; Wada Y; Yoshikawa K; Takasu C; Tokunaga T; Nakao T; Kashihara H; Yoshimoto T; Noma T; Shimada M
J Med Invest; 2024; 71(1.2):148-153. PubMed ID: 38735711
[TBL] [Abstract] [Full Text] [Related]
15. Low prognostic nutrition index as a prognostic biomarker in elderly patients with early gastric cancer after gastrectomy.
Takahashi T; Kaneoka Y; Maeda A; Takayama Y; Aoyama H; Hosoi T; Seita K
J Med Invest; 2024; 71(1.2):113-120. PubMed ID: 38735706
[TBL] [Abstract] [Full Text] [Related]
16. Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines.
Saeedi F; Salehi M; Kamali MJ; Mir MA; Kazemi S; Shirafkan F; Neyshaburi EZ; Moeeni R; Gorji N; Memariani Z
Med Oncol; 2024 May; 41(6):148. PubMed ID: 38733486
[TBL] [Abstract] [Full Text] [Related]
17. An In Vitro Study on the Cytotoxic, Antioxidant, and Antimicrobial Properties of Yamogenin-A Plant Steroidal Saponin and Evaluation of Its Mechanism of Action in gastric cancer Cells.
Stefanowicz-Hajduk J; Graczyk P; Hering A; Gucwa M; Nowak A; Hałasa R
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731847
[TBL] [Abstract] [Full Text] [Related]
18. The influence of delayed gastric emptying on quality of life after partial duodenopancreatectomy.
Klein M; Warschkow R; Ukegjini K; Krstic D; Burri P; Chatziisaak D; Steffen T; Schmied B; Probst P; Tarantino I
Langenbecks Arch Surg; 2024 May; 409(1):155. PubMed ID: 38727871
[TBL] [Abstract] [Full Text] [Related]
19. Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: a systematic review and meta-analysis.
Guchelaar NAD; Nasserinejad K; Mostert B; Koolen SLW; van der Sluis PC; Lagarde SM; Wijnhoven BPL; Mathijssen RHJ; Noordman BJ
Br J Surg; 2024 May; 111(5):. PubMed ID: 38722803
[TBL] [Abstract] [Full Text] [Related]
20. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract] [Full Text] [Related]
[Next]